Table 1.

Comparison of patient and embryological characteristics of RecT and RobT carriers

	RecT	RobT	p value	Female RecT	Female RobT	p value	Male RecT	Male RobT	p value
No. of patients	95	36	-	46	18	-	49	18	-
No. of cycles	124	49	-	55	21	-	69	21	-
Female age (years)	32 (28–34)	31 (28–5)	0.934	31 (28–33)	32 (27–35)	0.608	32 (28–34.5)	31 (28.25–35)	0.879
Male age (years)	34(31–37)	34(31–37)	0.599	34 (31–37)	35 (31.5–39)	0.057	34 (31–37)	32.5 (31–35.75)	0.543
BMI (kg/m2)	23.10 (20.77–25.10)	24.31 (21.67–28.93)	0.156	23.80 (22.08–26.04)	23.83 (23.1–28.93)	1.000	22.83 (20.3–24.61)	25.95 (21.67–29)	0.589
Total gonadotropin dosage (IU)	2475 (1846.5–3000)	2325 (1800–3000)	0.111	2400 (1827.75–3000)	2400 (1837.5–3150)	0.829	2512.5 (1950–3225)	2362.5 (1943.75–2962.5)	0.087
Sperm concentration (million/ml)	30 (10–60)	20 (0.9–54.5)	0.310	40 (25–70)	55 (31–80)	0.305	20 (5–35.5)	2 (0.3–18.25)	0.004
No. of oocytes	12 (7–18)	10 (5.50–18.50)	0.439	13 (9–20)	10 (5–19)	0.457	10 (6.5–17.5)	11 (6–16.75)	0.968
No. of MII	9 (6–13)	9 (4–13)	0.926	11 (6–16)	9 (4–15.5)	0.162	9 (5.5–12)	9.5 (4–12)	0.306
No. of 2PN	7 (4–7)	7 (3.–10)	0.932	9 (5–13)	7 (3.5–10.5)	0.264	6 (4–10)	8.5 (3.25–10)	0.584
Fertilization rate (%)	80 (66.67–92.37)	81.82 (74.34–100)	0.7	81.82 (72.73–92.86)	81.82 (75–100)	0.818	80 (66.67–92.33)	85.91 (71.99–100)	0.676
Blastocyst rate (%)	50 (28.14–64.15)	50 (40–67.71)	0.530	50 (31.58–66.67)	57.14 (50–70.5)	0.569	50 (27.05–61.25)	48.08 (33.33–55.56)	0.9
No. of embryos analyzed	3 (2–4)	3 (2–4.50)	0.593	3 (2–5)	3 (2–5.5)	0.843	2 (1.5–4)	2 (2–4)	0.763

IU, international unite; MII, metaphase 2 oocyte; 2PN, two pronuclei